Literature DB >> 5002904

Production of L-arginine by arginine hydroxamate-resistant mutants of Bacillus subtilis.

M Kisumi, J Kato, M Sugiura, I Chibata.   

Abstract

l-Arginine hydroxamate inhibited the growth of various bacteria, and the inhibition was readily reversed by arginine. l-Arginine hydroxamate (10(-3)m) completely inhibited the growth of Bacillus subtilis. This inhibitory effect was prevented by 2.5 x 10(-4)ml-arginine, which was the most effective of all the natural amino acids in reversing the inhibition. l-Arginine hydroxamate-resistant mutants of Bacillus subtilis were isolated and found to excrete l-arginine in relatively high yields. One of the mutants, strain AHr-5, produced 4.5 mg of l-arginine per ml in shaken culture in 3 days.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5002904      PMCID: PMC376473          DOI: 10.1128/am.22.6.987-991.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  18 in total

1.  Homoarginine inhibition of Escherichia coli B.

Authors:  J B WALKER
Journal:  J Biol Chem       Date:  1955-02       Impact factor: 5.157

2.  Genetics of regulation of enzyme synthesis in the arginine biosynthetic pathway of Escherichia coli.

Authors:  L GORINI; W GUNDERSEN; M BURGER
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1961

3.  Selection of bacterial mutants which excrete antagonists of antimetabolites.

Authors:  E A ADELBERG
Journal:  J Bacteriol       Date:  1958-09       Impact factor: 3.490

4.  Canavanine and homoarginine as antimetabolites of arginine and lysine in yeast and algae.

Authors:  J B WALKER
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

5.  TRANSFORMATION OF BIOCHEMICALLY DEFICIENT STRAINS OF BACILLUS SUBTILIS BY DEOXYRIBONUCLEATE.

Authors:  J Spizizen
Journal:  Proc Natl Acad Sci U S A       Date:  1958-10-15       Impact factor: 11.205

6.  Studies on repression of arginine biosynthesis in Escherichia coli.

Authors:  W K MAAS
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1961

7.  Pathway-specific pattern of control of arginine biosynthesis in bacteria.

Authors:  S Udaka
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

8.  Increase in isoleucine accumulation by alpha-aminobutyric acid-resistant mutants of Serratia marcescens.

Authors:  M Kisumi; J Kato; S Komatsubara; I Chibata
Journal:  Appl Microbiol       Date:  1971-04

9.  Isoleucine hydroxamate, an isoleucine antagonist.

Authors:  M Kisumi; S Komatsubara; M Sugiura; I Chibata
Journal:  J Bacteriol       Date:  1971-09       Impact factor: 3.490

10.  Valine accumulation by alpha-aminobutyric acid-resistant mutants of Serratia marcescens.

Authors:  M Kisumi; S Komatsubara; I Chibata
Journal:  J Bacteriol       Date:  1971-05       Impact factor: 3.490

View more
  5 in total

1.  Increase in arginine and citrulline production by 6-azauracil-resistant mutants of Bacillus subtilis.

Authors:  J Kato; M Kisumi; T Takagi; I Chibata
Journal:  Appl Environ Microbiol       Date:  1977-12       Impact factor: 4.792

2.  Reengineering of the feedback-inhibition enzyme N-acetyl-L-glutamate kinase to enhance L-arginine production in Corynebacterium crenatum.

Authors:  Jingjing Zhang; Meijuan Xu; Xiaoxun Ge; Xian Zhang; Taowei Yang; Zhenghong Xu; Zhiming Rao
Journal:  J Ind Microbiol Biotechnol       Date:  2016-12-22       Impact factor: 3.346

3.  Production of L-phenylalanine by DL-phenylalanine hydroxamate-resistant Tyr- mutants of Bacillus subtilis.

Authors:  J J McEvoy; A Joyce
Journal:  Mol Cell Biochem       Date:  1974-10-30       Impact factor: 3.396

4.  Metabolic engineering of microorganisms for the production of L-arginine and its derivatives.

Authors:  Jae Ho Shin; Sang Yup Lee
Journal:  Microb Cell Fact       Date:  2014-12-03       Impact factor: 5.328

5.  Effect of Tween 40 and DtsR1 on L-arginine overproduction in Corynebacterium crenatum.

Authors:  Minliang Chen; Xuelan Chen; Fang Wan; Bin Zhang; Jincong Chen; Yonghua Xiong
Journal:  Microb Cell Fact       Date:  2015-08-12       Impact factor: 5.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.